ROIV Hisse Senedi Fiyat Grafiği
ROIV Finansal
Roivant Sciences Ltd
$35.39
0.74%
$0.25
Kapanışta: Jul 06, 16:00:00 GMT-4
$35.81
1.18%
$0.42
Ön Piyasa: Jul 07, 09:33:50 GMT-4
Geri
Roivant Sciences Ltd (ROIV) Finansal
Önemli İstatistikler
Önceki Kapanış
$35.13
Açılış fiyatı
$34.85
Günün Aralığı
$34.83 - $35.81
52 haftalık aralık
$10.7 - $35.81
İşlem hacmi
5.7M
Ort.Hacim
6.0M
Dividend yield
--
EPS (TTM)
-0.45
Piyasa Değeri
$25.7B
ROIV nedir?
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
